These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1630 related items for PubMed ID: 29996343

  • 1. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J, Zheng JP, Shao GL, Wen S, Guo LW, Zeng H, Zhang L, Qian CY, Hao WY.
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr 20; 26(4):298-304. PubMed ID: 29996343
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of transcatheter arterial chemoembolization combined with either 125I seed implantation or apatinib in hepatocellular carcinoma with portal vein tumor thrombosis: A retrospective comparative study.
    Li Y, Li H, Hu H, Yuan H, Zhao Y.
    J Cancer Res Ther; 2020 Apr 20; 16(7):1691-1697. PubMed ID: 33565518
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.
    Ye HH, Ye JZ, Xie ZB, Peng YC, Chen J, Ma L, Bai T, Chen JZ, Lu Z, Qin HG, Xiang BD, Li LQ.
    World J Gastroenterol; 2016 Apr 07; 22(13):3632-43. PubMed ID: 27053855
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M, Wang JP, Li W, Huang ZL, Zhang FJ, Fan WJ, Zhang L, Li XS, Pan CC, Wu PH.
    Zhonghua Yi Xue Za Zhi; 2011 May 10; 91(17):1167-72. PubMed ID: 21756768
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Endovascular implantation of 125I seed combined with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma.
    Sun H, Zhang M, Liu R, Liu Y, Hou Y, Wu C.
    Future Oncol; 2018 May 10; 14(12):1165-1176. PubMed ID: 29334777
    [Abstract] [Full Text] [Related]

  • 11. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus.
    Zhang ZH, Liu QX, Zhang W, Ma JQ, Wang JH, Luo JJ, Liu LX, Yan ZP.
    World J Gastroenterol; 2017 Nov 21; 23(43):7735-7745. PubMed ID: 29209114
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.
    Ding X, Sun W, Li W, Shen Y, Guo X, Teng Y, Liu X, Zheng L, Li W, Chen J.
    Cancer; 2021 Oct 15; 127(20):3782-3793. PubMed ID: 34237154
    [Abstract] [Full Text] [Related]

  • 18. Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study.
    Zhang L, Sun JH, Hou ZH, Zhong BY, Yang MJ, Zhou GH, Wang WS, Huang P, Zhang S, Li Z, Zhu XL, Yan ZP, Ni CF.
    Cardiovasc Intervent Radiol; 2021 Jan 15; 44(1):63-72. PubMed ID: 32965582
    [Abstract] [Full Text] [Related]

  • 19. Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas.
    Ni JY, Kong J, Sun HL, Chen YT, Luo JH, Wang WD, Chen D, Jiang XY, Xu LF.
    Acad Radiol; 2018 Apr 15; 25(4):423-429. PubMed ID: 29198946
    [Abstract] [Full Text] [Related]

  • 20. Transarterial Chemoembolization (TACE) Combined with Sorafenib in Treatment of HBV Background Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Propensity Score Matching Study.
    Yuan J, Yin X, Tang B, Ma H, Zhang L, Li L, Chen R, Xie X, Ren Z.
    Biomed Res Int; 2019 Apr 15; 2019():2141859. PubMed ID: 31467872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 82.